VENT OR NOT: Intubation of Obese Patients in the Operating Room With or Without Bag-Mask Ventilation

Sponsor
Nantes University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05930678
Collaborator
(none)
702
8
2
24
87.8
3.7

Study Details

Study Description

Brief Summary

The aim of the study is to answer a daily question in the operating room: what is the safest technique for intubation of severe/morbid obese patients (BMI 35 or more). There is a great heterogeneity of practices on the subject, so the principle is to determine a common practice to facilitate the management of these patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: No ventilation with face mask
  • Procedure: Ventilation with face mask
N/A

Detailed Description

Anesthesia consultation or pre-anesthesia visit:
  • screening for inclusion and non-inclusion criteria

  • patient information

  • collection of consent

  • inclusion

D0 (day of inclusion):
  • before general anesthesia : collection of epidemiological data (history + clinical examinations) + randomization (Arm A/Not Vent : intubation without ventilation or Arm B/Vent : intubation with ventilation)

  • general anesthesia : intubation according to randomization arm + collection primary endpoint + conduct of the intubation procedure + morbidity of the intubation procedure

  • after general anesthesia : collection of secondary endpoints + conduct of the intubation procedure + morbidity of the intubation procedure + intraoperative respiratory morbidity

  • post-interventional care room : collection of clinical parameters in the ICU : postoperative morbidity + study discharge (hospital discharge)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
702 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Morbidly obese patients (BMI greater than or equal to 35).Morbidly obese patients (BMI greater than or equal to 35).
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Intubation of Obese Patients in the Operating Room With or Without Bag-Mask Ventilation. A Randomized Multicentre Study
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Without ventilation

No ventilation sequence during the intubation period and without face mask ventilation during the apnea period

Procedure: No ventilation with face mask
During the period of apnea (in general anesthesia), the patient did not help with face mask

Experimental: With ventilation

Sequence "with ventilation" during the apnea period with face mask ventilation

Procedure: Ventilation with face mask
During the pperiod of apnea (in general anesthesia), the patient did help with face mask

Outcome Measures

Primary Outcome Measures

  1. To compare the effectiveness of an intubation sequence "with ventilation during apnea" versus a sequence "without ventilation during apnea" in preventing complications related to intubation of the obese patient in the operating room [From induction of general anesthesia to 10 minutes after intubation]

    Comparison of the incidence of intubation-related complications. Complications identified for the primary endpoint will be: desaturations < 95%, need for 2 or more intubation attempts (including alternative technique), occurrence of inhalation/regurgitation or hypotension with systolic blood pressure < 80 mmHg, with or without amine. Complications will be recorded from induction of general anesthesia to 10 minutes after intubation

Secondary Outcome Measures

  1. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 8 hours]

    Difficulty with mask ventilation (yes/no)

  2. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 10 minutes]

    Measure of the saturation before the first laryngoscopy with oximeter

  3. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 10 minutes]

    Measure of the lowest saturation during the intubation procedure and the following 10 minutes

  4. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 8 hours]

    Quality of exposure under laryngoscopy (position of the patient)

  5. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 8 hours]

    Difficulties in intubation (yes/no)

  6. Impact of the nature of the intubation sequence on the progress of the intubation procedure between patient with face mask and patient without face mask [During the general anesthesia, up to 8 hours]

    Description of intubation (mandrin, videolaryngoscope, videolaryngoscope)

  7. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Rate of desaturation <80% (yes/no)

  8. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Rate of desaturation <90% (yes/no)

  9. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Presence of severe hypotension during intubation and in the following hour defined by a systolic blood pressure < 80 mmHg, with or without amine (yes/no)

  10. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Number of participants with cardiac arrest

  11. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Death during intubation

  12. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Difficulties in intubations (yes/no) with the number of intubation attempts

  13. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Number of participants with cardiac rhythm disorders

  14. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Number of participants with esophageal intubations

  15. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Number of participants with regurgitation/inhalation

  16. Impact of the nature of the intubation sequence on morbidity related to the intubation procedure between patient with face mask and patient without face mask [up to 8 hours]

    Number of participants with dental breaks

  17. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [5 minutes, 30 minutes and 1 hour after intubation]

    Need for FiO2 >50% during surgery to achieve >95% saturation (yes/no)

  18. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Length of stay in the post-operation monitoring room

  19. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Duration of postoperative mechanical ventilation(in minutes)

  20. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Number of participants with nausea

  21. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Number of participants with vomiting

  22. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Length of hospitalization since randomization

  23. Impact of the nature of the intubation sequence on immediate intraoperative and postoperative respiratory morbidity between patient with face mask and patient without face mask [up to 28 days]

    Hospital discharge status (dead/alive)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • patient requiring general anesthesia with intubation for surgery or scheduled endoscopic procedures

  • age > 18 years

  • with a BMI superior or equal to 35kg.m-²

  • patient having signed an informed consent

Non-inclusion criteria:
  • ambient air saturation <90%

  • urgent surgery < 24 hours

  • cardio-thoracic surgery

  • mask ventilation not possible (e.g. ATCD, cervical irradiation, fixed mandible)

  • formal contraindication to mask ventilation (e.g. occlusive syndrome, non fasting patient, symptomatic gastroesophageal reflux untreated or persistent under treatment)

  • wish of the operator for high flow oxygen preoxygenation

  • wish of an intubation without curare by the operator

  • pregnant or breast-feeding women

  • protected adults (guardianship, curatorship or safeguard of justice)

  • participation in another randomized clinical research study concerning preoxygenation and relevant to the primary endpoint

  • absence of affiliation to the French social security system

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Nantes Nantes Loire Atlantique France 44100
2 CHU Angers Angers France 49933
3 CHRU Brest Brest France 29609
4 HCL - Hôpital Edouard Herriot Lyon France
5 CHU Poitiers Poitiers France 86021
6 CHU Toulouse Toulouse France 31300
7 CHRU Tours Tours France 37000
8 CH de Valenciennes Valenciennes France

Sponsors and Collaborators

  • Nantes University Hospital

Investigators

  • Principal Investigator: Mickael VOURC'H, PhD, CHU de Nantes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT05930678
Other Study ID Numbers:
  • RC22_0359
First Posted:
Jul 5, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023